tradingkey.logo
tradingkey.logo
Search

Tonix Pharmaceuticals Holding Corp

TNXP
Add to Watchlist
10.635USD
+0.045+0.42%
Close 07-23 16:00ETQuotes delayed by 15 min
136.00MMarket Cap
LossP/E TTM

TNXP Financials

See Tonix Pharmaceuticals Holding Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Tonix Pharmaceuticals Holding Corp Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-2.93/-2.43
Revenue / Forecast
6.88M/6.13M
Period
FY2025 Earnings
Revenue(YoY)
13.11M
29.85%
EPS(YoY)
-14.57
99.92%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-3.28%-2.93
59.64%-3.96
84.32%-3.59
99.80%-3.86
99.52%-2.84
99.64%-9.82
99.61%-22.88
77.50%-1.93K
94.33%-591.07
75.18%-2.74K
---5.84K
---8.57K
---10.42K
---11.04K
---61.18K
----
----
----
----
----
Revenue
183.16%6.88M
108.75%5.39M
16.58%3.29M
-9.51%2.00M
-2.14%2.43M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
--3.78M
--3.99M
----
----
----
----
----
----
----
----
----
Net Profit
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-15.33%-34.08M
-56.42%-28.98M
-16.31%-27.39M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
Net Margin
15.65%-584.38%
-1.64%-870.32%
-93.18%-972.95%
60.34%-1415.02%
-15.11%-692.84%
-18.43%-856.24%
28.18%-503.65%
---3567.75%
---601.89%
---723.00%
---701.30%
----
----
----
----
----
----
----
----
----
Gross Margin
25.96%77.06%
48.33%80.37%
30.19%58.45%
-21.48%-63.76%
84.72%61.18%
45.01%54.18%
10.89%44.90%
---52.49%
--33.12%
--37.36%
--40.49%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-20.33%4.60%
--8.41%
--12.07%
--6.63%
--5.77%
----
----
----
----
----
----
----
----
----
----
Revenue
183.16%6.88M
108.75%5.39M
16.58%3.29M
-9.51%2.00M
-2.14%2.43M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
--3.78M
--3.99M
----
----
----
----
----
----
----
----
----
Operating profit
-158.73%-41.54M
-114.80%-48.29M
-112.59%-33.07M
-54.13%-28.30M
24.81%-16.05M
17.74%-22.48M
44.74%-15.55M
36.70%-18.36M
37.02%-21.35M
16.50%-27.33M
4.88%-28.15M
-24.28%-29.00M
-28.24%-33.90M
-11.02%-32.73M
-59.65%-29.59M
0.96%-23.34M
-27.49%-26.44M
-73.17%-29.48M
-54.47%-18.54M
-66.02%-23.56M
Net Profit
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-15.33%-34.08M
-56.42%-28.98M
-16.31%-27.39M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
Current assets
38.51%207.17M
92.33%228.88M
311.67%208.07M
467.62%143.53M
396.95%149.57M
149.12%119.00M
61.29%50.54M
-50.74%25.29M
-64.05%30.10M
-63.47%47.77M
-79.27%31.34M
-73.23%51.33M
-45.27%83.73M
-30.82%130.78M
-22.53%151.14M
8.17%191.75M
-11.65%152.99M
114.86%189.05M
214.56%195.08M
207.61%177.27M
Total current liabilities
144.09%29.65M
68.44%30.84M
38.54%21.03M
-13.53%19.06M
-40.69%12.15M
-3.06%18.31M
-14.39%15.18M
19.53%22.04M
56.65%20.48M
3.87%18.88M
32.93%17.73M
15.92%18.44M
-14.86%13.07M
-16.28%18.18M
10.93%13.34M
96.87%15.91M
154.71%15.35M
121.16%21.72M
174.69%12.03M
72.74%8.08M
Total assets
33.72%257.91M
70.16%277.17M
165.76%252.44M
166.49%187.36M
42.50%192.87M
5.46%162.89M
-31.80%94.99M
-55.99%70.31M
-24.43%135.34M
-31.56%154.46M
-42.60%139.28M
-42.16%159.74M
-19.95%179.09M
-6.31%225.69M
12.98%242.65M
45.99%276.17M
21.90%223.72M
145.36%240.90M
217.63%214.77M
224.22%189.16M
Total liabilities
146.71%30.77M
37.24%32.02M
2.50%21.30M
-31.36%19.36M
-54.14%12.47M
-52.32%23.33M
12.62%20.78M
46.34%28.20M
99.11%27.20M
164.38%48.93M
34.45%18.45M
17.64%19.27M
-13.31%13.66M
-16.57%18.51M
9.29%13.72M
88.92%16.38M
138.59%15.76M
110.56%22.18M
148.68%12.56M
81.69%8.67M
Total equity
25.91%227.14M
75.66%245.15M
211.47%231.14M
299.02%168.00M
66.81%180.40M
32.25%139.56M
-38.58%74.21M
-70.03%42.10M
-34.63%108.14M
-49.07%105.53M
-47.22%120.83M
-45.93%140.46M
-20.45%165.43M
-5.27%207.18M
13.21%228.92M
43.93%259.78M
17.55%207.96M
149.54%218.72M
223.20%202.22M
236.92%180.49M
Net operating income
-155.25%-42.32M
-171.02%-39.65M
-53.09%-28.78M
-49.54%-14.83M
5.67%-16.58M
34.51%-14.63M
19.60%-18.80M
57.55%-9.92M
46.60%-17.57M
-0.17%-22.34M
0.64%-23.39M
-10.37%-23.37M
-6.01%-32.91M
0.64%-22.30M
-81.79%-23.54M
-10.80%-21.17M
-47.43%-31.05M
-61.31%-22.45M
15.30%-12.95M
-90.30%-19.11M
Net investment
-28100.00%-1.69M
-33933.33%-1.02M
-10588.89%-962.00K
---2.54M
94.44%-6.00K
99.30%-3.00K
98.90%-9.00K
100.00%0.00
97.16%-108.00K
90.77%-431.00K
90.69%-821.00K
-66.35%-24.02M
81.21%-3.80M
81.77%-4.67M
-13.79%-8.82M
-910.43%-14.44M
-3903.37%-20.22M
-465.11%-25.62M
-93.00%-7.75M
-10107.14%-1.43M
Net financing
-59.21%20.20M
-30.55%59.14M
121.10%94.86M
56.48%10.99M
23464.62%49.53M
109.15%85.15M
583.85%42.91M
582.70%7.03M
98.16%-212.00K
463.20%40.71M
235.65%6.27M
-98.57%1.03M
-188.03%-11.50M
-83.48%7.23M
-112.18%-4.63M
227.35%72.18M
-87.98%13.06M
9.80%43.77M
89.15%37.96M
-35.94%22.05M

FAQs

What is the total revenue of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its total revenue reached 13.11M, with a year-on-year change of 10.09M.

What are the current assets of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its current assets were 228.88M, with a year-on-year change of 92.33.

What are the total assets of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its total assets of Tonix Pharmaceuticals Holding Corp were 277.17M, with a year-on-year change of 70.16.

What are the total liabilities of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its total liabilities of Tonix Pharmaceuticals Holding Corp were 32.02M, with a year-on-year change of 37.24.

What is the total equity of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its total equity of Tonix Pharmaceuticals Holding Corp was 245.15M, with a year-on-year change of 75.66.

What is the net operating income of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its net operating income of Tonix Pharmaceuticals Holding Corp was -125.70M, with a year-on-year change of -61.69.

What is the net investment of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its net investment of Tonix Pharmaceuticals Holding Corp was -4.53M, with a year-on-year change of -3673.33.

What is the net financing of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its net financing of Tonix Pharmaceuticals Holding Corp was 214.53M, with a year-on-year change of 59.06.

What is the Earnings Per Share (EPS) of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -14.57, with a year-on-year change of 99.92.

What is the net income of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its net income was -124.02M, with a year-on-year change of 4.63.

What is the net margin of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its net profit margin was -946.22, with a year-on-year change of 26.55.

What is the gross margin of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its gross margin was 49.34, with a year-on-year change of 113.84.

What is the Return on Equity (ROE) of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its Return on Equity (ROE) was -64.48, with a year-on-year change of 39.24.

What is the Return on Assets (ROA) of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its Return on Assets (ROA) was -56.37, with a year-on-year change of 31.22.

What is the operating profit of Tonix Pharmaceuticals Holding Corp?

According to Tonix Pharmaceuticals Holding Corp's FY2025 earnings report, its operating profit was -125.70M, with a year-on-year change of -61.69.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.